Figueroa-Sánchez JA, Martínez PÁ, Pérez-Cárdenas S, Benvenutti-Regato M

Language: Spanish
References: 13
Page: 230-233
PDF size: 99.55 Kb.

ABSTRACT

Neurocysticercosis (Nc) is a worldwide frequent cause of neurological disorders in some endemic areas. Our perception it is a diminished incidence, changes in its clinical presentation and treatment. Objective: herein, we present our 10 years experience on the Nc treatment at the Neurosurgery and Neurological Endovascular Therapy Service at the «Dr. José Eleuterio González» University Hospital. Patients and methods: we performed a retrospective study of all patients admitted to our hospital with Nc between October 2000 to October 2010. The data were obtained from the clinical and radiological files; those cases without a registered file where excluded. Epidemologic variables, like age and sex, and the most significative clinical findings were analyzed. Results: we included 99 patients 65 men and 34 women with a mean age of 45.9 years. A decrease on frequency of the Nc incidence through time was seen with statistical significance (pd» 0,001). The clinical presentation also showed variation mainly in seizures and clinical data of intracranial hypertension. Twenty six patients underwent a surgical procedure. Conclusion: the change in the frequency of the disease and its clinical presentation, are the result of multiple factors, in particular the actions undertaken by the National Health System in our country. The statistical analysis shows a clear trend in the decrease of Nc frequency; however, more national and international studies are needed to support this trend.

REFERENCES

1. Albores-Saavedra J, Altamirano-Dimas M. Algunas consideraciones sobre 9412 autopsias realizadas en el Hospital General de México. Gac Med Mex 1971;102:193-203.

2. Larralde C, Padilla A, Hernández M. Seroepidemiología de la cisticercosis en México. Salud Pública Méx 1992; 34(2):197- 210.

3. McCormick G. Cysticercosis-review of 230 patients. Bull Clin Neurosci 1985;50:76-101.

4. Aluja A, Escobar A, Escobedo F. Cisticercosis. Una recopilación actualizada de los conocimientos básicos para el manejo y control de la cisticercosis causada por Taenia solium. México, D.F.: FCE, 1987.

5. Ana Flisser, Plancarte A, Avila G. Aplicación de métodos de diagnóstico de cisticercosis y teniasis a estudios epidemiológicos, Teniasis/Cisticercosis García/S.M. Martínez M. Editores, 1996, 17-31.

6. White AC Jr. Neurocysticercosis updates on epidemiology, pathogenesis, diagnosis and management. Ann Rev Med 2000;51:187-206.

7. Medina MT, DeGiorgio C. Introduction to neurocysticercosis: a worldwide epidemic. Neurosurg Focus 2002;12:6.

8. Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 2004;19:323-7.

9. Evans C, Garcia H, Gilman R. Controversies in the management of cysticercosis. Emerg Infect Dis 1997;3:403-5

10. Rajshekhar V, Oommen A. Serological studies using ELISA and EITB in patients with solitary cysticercus granuloma and seizures. Neurol Infect Epidemiol 1997;2:177-80.

11. Del Brutto O, Roos K, Coffey C. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51.

12. Del Brutto OH, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis 1988; 10(6): 1075-87.

13. Garcia H, Evans C, Nash T. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15:747-56.